Literature DB >> 10681353

Iron-chelating activity of tetracyclines and its impact on the susceptibility of Actinobacillus actinomycetemcomitans to these antibiotics.

D Grenier1, M P Huot, D Mayrand.   

Abstract

Three tetracyclines (tetracycline, doxycycline, and minocycline) were found to possess iron-chelating activity in a colorimetric siderophore assay. Determination of MICs indicated that the activity of doxycycline against the periodontopathogen Actinobacillus actinomycetemcomitans was only slightly influenced by the presence of an excess of iron that likely saturates the antibiotic. On the other hand, the MICs of doxycycline and minocycline were significantly lower for A. actinomycetemcomitans cultivated under iron-poor conditions than under iron-rich conditions.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10681353      PMCID: PMC89761          DOI: 10.1128/AAC.44.3.763-766.2000

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  26 in total

Review 1.  Iron and infection.

Authors:  J R Boelaert
Journal:  Acta Clin Belg       Date:  1996       Impact factor: 1.264

Review 2.  Microbial etiological agents of destructive periodontal diseases.

Authors:  A D Haffajee; S S Socransky
Journal:  Periodontol 2000       Date:  1994-06       Impact factor: 7.589

3.  The detection of four molecular forms of human transferrin during the iron binding process.

Authors:  D G Makey; U S Seal
Journal:  Biochim Biophys Acta       Date:  1976-11-26

4.  Universal chemical assay for the detection and determination of siderophores.

Authors:  B Schwyn; J B Neilands
Journal:  Anal Biochem       Date:  1987-01       Impact factor: 3.365

5.  Minocycline reduces gingival collagenolytic activity during diabetes. Preliminary observations and a proposed new mechanism of action.

Authors:  L M Golub; H M Lee; G Lehrer; A Nemiroff; T F McNamara; R Kaplan; N S Ramamurthy
Journal:  J Periodontal Res       Date:  1983-09       Impact factor: 4.419

6.  Tetracyclines inhibit human synovial collagenase in vivo and in vitro.

Authors:  R A Greenwald; L M Golub; B Lavietes; N S Ramamurthy; B Gruber; R S Laskin; T F McNamara
Journal:  J Rheumatol       Date:  1987-02       Impact factor: 4.666

7.  The role of crevicular fluid iron in periodontal disease.

Authors:  S Mukherjee
Journal:  J Periodontol       Date:  1985-11       Impact factor: 6.993

Review 8.  Transferrins and heme-compounds as iron sources for pathogenic bacteria.

Authors:  B R Otto; A M Verweij-van Vught; D M MacLaren
Journal:  Crit Rev Microbiol       Date:  1992       Impact factor: 7.624

Review 9.  Blocking periodontal disease progression by inhibiting tissue-destructive enzymes: a potential therapeutic role for tetracyclines and their chemically-modified analogs.

Authors:  B R Rifkin; A T Vernillo; L M Golub
Journal:  J Periodontol       Date:  1993-08       Impact factor: 6.993

10.  The antagonism of tetracycline and ferric iron in vivo.

Authors:  A A Miles; J P Maskell
Journal:  J Med Microbiol       Date:  1985-08       Impact factor: 2.472

View more
  26 in total

1.  In vitro activities of antibiotics against Plasmodium falciparum are inhibited by iron.

Authors:  B Pradines; C Rogier; T Fusai; J Mosnier; W Daries; E Barret; D Parzy
Journal:  Antimicrob Agents Chemother       Date:  2001-06       Impact factor: 5.191

Review 2.  Interactions among strategies associated with bacterial infection: pathogenicity, epidemicity, and antibiotic resistance.

Authors:  José L Martínez; Fernando Baquero
Journal:  Clin Microbiol Rev       Date:  2002-10       Impact factor: 26.132

3.  Discovery of nicoyamycin A, an inhibitor of uropathogenic Escherichia coli growth in low iron environments.

Authors:  Laura A Mike; Ashootosh Tripathi; Connor M Blankenship; Alyssa Saluk; Pamela J Schultz; Giselle Tamayo-Castillo; David H Sherman; Harry L T Mobley
Journal:  Chem Commun (Camb)       Date:  2017-11-28       Impact factor: 6.222

4.  Tissue-specific expression of ferritin H regulates cellular iron homoeostasis in vivo.

Authors:  John Wilkinson; Xiumin Di; Kai Schönig; Joan L Buss; Nancy D Kock; J Mark Cline; Thomas L Saunders; Hermann Bujard; Suzy V Torti; Frank M Torti
Journal:  Biochem J       Date:  2006-05-01       Impact factor: 3.857

5.  Minocycline-induced attenuation of iron overload and brain injury after experimental intracerebral hemorrhage.

Authors:  Fan Zhao; Ya Hua; Yangdong He; Richard F Keep; Guohua Xi
Journal:  Stroke       Date:  2011-10-13       Impact factor: 7.914

6.  Iron blocks the accumulation and activity of tetracyclines in bacteria.

Authors:  Angela M Avery; Helen J Goddard; Edward R Sumner; Simon V Avery
Journal:  Antimicrob Agents Chemother       Date:  2004-05       Impact factor: 5.191

Review 7.  Iron and intracerebral hemorrhage: from mechanism to translation.

Authors:  Xiao-Yi Xiong; Jian Wang; Zhong-Ming Qian; Qing-Wu Yang
Journal:  Transl Stroke Res       Date:  2013-12-21       Impact factor: 6.829

8.  A drug-repositioning screening identifies pentetic acid as a potential therapeutic agent for suppressing the elastase-mediated virulence of Pseudomonas aeruginosa.

Authors:  Mia Gi; Junhui Jeong; Keehoon Lee; Kang-Mu Lee; Masanori Toyofuku; Dong Eun Yong; Sang Sun Yoon; Jae Young Choi
Journal:  Antimicrob Agents Chemother       Date:  2014-09-22       Impact factor: 5.191

9.  Potent synergistic effect of doxycycline with fluconazole against Candida albicans is mediated by interference with iron homeostasis.

Authors:  Alessandro Fiori; Patrick Van Dijck
Journal:  Antimicrob Agents Chemother       Date:  2012-05-07       Impact factor: 5.191

Review 10.  Progress in translational research on intracerebral hemorrhage: is there an end in sight?

Authors:  Guohua Xi; Jennifer Strahle; Ya Hua; Richard F Keep
Journal:  Prog Neurobiol       Date:  2013-10-16       Impact factor: 11.685

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.